Cite

HARVARD Citation

    Cahn, P. et al. (2022). Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy – naive adults with HIV-1 infection. AIDS. pp. 39-48. [Online]. 
  
Back to record